← Eichor
Study identifier: NCT05236348 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Condition: Hypertension · Blood Pressure · Heart Rate  ·  Sponsor: Aktiia SA

PhaseNA
Planned participants225
Who can joinAll sexes, 21 Years to 85 Years
Healthy volunteersYes

About this study

This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.

This description comes directly from the study's public registry record.

Talk to the study team

Josep Sola, PhD  ·  +41797689800  ·  josep@aktiia.com

Always discuss trial participation with your own doctor first.

Locations (1)

University of Lausanne HospitalsLausanne, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05236348